与2型糖尿病视网膜病变相关的因素及其临床应用价值
Xue-Nan Lian1,2, Ming-Ming Zhu2
1School of Graduate Studies, Hebei North University, Zhangjiakou, China.
Frontiers in endocrinology
|December 5, 2024
概括
本研究确定了影响2型糖尿病 (T2DM) 患者糖尿病视网膜病变 (DR) 的关键临床因素. 高肌和特定的血管疾病是风险,而高2小时的食后C-可能是保护性的.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 血管医学 血管医学
背景情况:
- 糖尿病视网膜病变 (DR) 是2型糖尿病 (T2DM) 的一个主要并发症.
- 确定与DR相关的临床因素对于患者管理和预防策略至关重要.
- 了解风险和保护因素可以改善T2DM患者的临床结果.
研究的目的:
- 为了比较T2DM患者与没有DR的临床因素.
- 确定T2DM患者DR发展的风险和保护因素.
主要方法:
- 对380名T2DM患者的回顾性分析.
- 数据收集包括基线特征,血液学测试,代谢指标,并发症和并发症.
- 后勤回归和逐步回归被用来构建DR的预测模型.
主要成果:
- 确定了DR的风险因素:干预,部血管疾病,双边下肢静脉血栓,高肌素,高球过率,高化物,高禁食C-和高乳酸脱酶.
- 确定了DR的保护因子:高2小时的食后C-.
- 开发了一个物流回归模型,准确度为0.80,DR预测的AUC为0.83.
结论:
- 特定的临床和实验室发现与T2DM患者的DR有显著的关联.
- 部血管疾病,静脉血栓症和肌水平升高被确定为危险因素.
- 2小时后食用C-的升高显示出对DR的保护作用,需要进一步调查.
更多相关视频
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
5.6K
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
3.5K
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Diabetes: Management and Pharmacotherapy
235
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
235
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
